Constantine Chinoporos insider trades: Applied Therapeutics (APLT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Constantine reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | APLT | ↓ Sell | 447 | $0.44 | $197 | Direct | Mar 6, 2025 (2d) |
| Feb 6, 2025 | APLT | ↓ Sell | 28,117 | $0.61 | $17K | Direct | Feb 7, 2025 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other APLT insiders
Open-market trades in the last 12 months
About Constantine Chinoporos's insider trades
Constantine Chinoporos is See Remarks at Applied Therapeutics (APLT). Since Feb 6, 2025, Constantine has reported no open-market purchases and 2 sales worth $17K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APLT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.